Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: A cross-sectional study

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Zheng, Tianpeng ^a   Gao, Yun ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

cell function; Lipids; Low density lipoprotein cholesterol; Normal glucose tolerance; Total cholesterol

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CHINA; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PANCREAS ISLET BETA CELL; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CHINA; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN-SECRETING CELLS; LINEAR MODELS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84868546221     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-634     Document Type: Article

References (31)

1. Plasma lipids and diabetes mellitus in an adult community. Barrett-Connor E, Grundy SM, Holdbrook MJ, Epidemiology 1982 115 657 663 (Pubitemid 12074271)
2. Diabetic dyslipidaemia. Betteridge DJ, Diabetes Obes Metab 2000 2 Suppl. 1 31 36
3. Cholesterol metabolism and pancreatic -cell function. Fryirs M, Barter PJ, Rye KA, Curr Opin Lipidol 2009 20 159 164 10.1097/MOL.0b013e32832ac180 19417651
4. Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. von Eckardstein A, Sibler RA, Curr Opin Lipidol 2011 22 26 32 10.1097/MOL.0b013e3283412279 21102330
5. Prevalence and Concomitants of Glucose Intolerance in European Obese Children and Adolescents. Invitti C, Guzzaloni G, Gilardini L, et al. Diabetes Care 2003 26 1118 1124
6. K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25years. Alvarsson M, Wajngot A, Cerasi E, et al. Diabetologia 2005 48 2262 2268 10.1007/s00125-005-1929-6 16160865 (Pubitemid 41618916)
7. Overweight, obesity, and their associations with insulin resistance and [beta]-cell function among Chinese: a cross-sectional study in China. Chen G, Liu C, Yao J, et al. Metabolism 2010 59 1823 1832 10.1016/j.metabol.2010.06.009 20655552
8. β-Cell Function Is a Major Contributor to Oral Glucose Tolerance in High-Risk Relatives of Four Ethnic Groups in the U.S. Jensen CC, Cnop M, Hull RL, et al. Diabetes 2002 51 2170 2178 10.2337/diabetes.51.7.2170 12086947 (Pubitemid 34729022)
9. Prevalence of diabetes among men and women in China. Yang W, Lu J, Weng J, et al. New Engl J Med 2010 362 1090 1101 10.1056/NEJMoa0908292 20335585
10. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Department of Noncommunicable Disease Surveillance, Part1.Diagnosis and classification of diabetes mellitus Geneva: World Health Organization 1999 Accessed February 26, 2010, at http://www.staff.ncl.ac.uk/ philip.home/who-dmg.pdf.
11. Luepker RV, Evans A, McKeigue P, et al. Cardiovascular survey methods Geneva: World Health Organization 3rd edition 2004
12. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, et al. Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
13. Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Brunham LR, Kruit JK, Pape TD, et al. Nat Med 2007 13 340 347 10.1038/nm1546 17322896 (Pubitemid 46376682)
14. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. Gerin I, Dolinsky VW, Shackman JG, et al. Biol Chem 2005 280 23024 23031 10.1074/jbc.M412564200 (Pubitemid 40861694)
15. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. Xia F, Gao X, Kwan E, et al. Biol Chem 2004 279 24685 24691 10.1074/jbc.M314314200 (Pubitemid 38725336)
16. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Hao M, Head WS, Gunawardana SC, et al. Diabetes 2007 56 2328 2338 10.2337/db07-0056 17575085 (Pubitemid 47358240)
17. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. Vikman J, Jimenez-Feltström J, Nyman P, et al. FASEB 2009 23 58 67 10.1096/fj.08-105734
18. Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: The DECODE Study. Zhang I, Qiao Q, Tuomilehto J, et al. Diabetes Res Clin Pract 2008 82 364 377 10.1016/j.diabres.2008.08.022 18922596
19. Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. Ishikawa M, Iwasaki Y, Yatoh S, et al. Lipid Res 2008 49 2524 2534 10.1194/jlr.M800238-JLR200
20. Low and high density lipoproteins modulate function, apoptosis and proliferation of primary human and murine pancreatic beta cells. Rutti S, Ehses JA, Sibler RA, et al. Endocrinology 2009 150 4521 4530 10.1210/en.2009-0252 19628574
21. Insulin-secreting beta-cell dysfunction induced by human lipoproteins. Roehrich ME, Mooser V, Lenain V, et al. Biol Chem 2003 278 18368 18375 10.1074/jbc.M300102200 (Pubitemid 36799458)
22. Metabolic consequences of hyperglycemia and insulin resistance. Jellinger PS, Clin Cornerstone 2007 8 Suppl. 7 30 42
23. Impaired beta-Cell Function and Deposition of Fat Droplets in the Pancreas as a Consequence of Hypertriglyceridemia in OLETF Rat, a Model of Spontaneous NIDDM. Man ZW, Zhu M, Noma Y, et al. Diabetes 1997 46 1718 1724 10.2337/diabetes.46.11.1718 9356017 (Pubitemid 27456402)
24. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse. Zhou YP, Berggren PO, Grill V, Diabetes 1996 45 5580 5586
25. Fatty acids induced -cells apoptosis: a link between obesity and diabetes. Shimabukuro M, Zhou YT, Levi M, et al. Proc Natl Acad Sci USA 1998 95 2498 2502 10.1073/pnas.95.5.2498 9482914 (Pubitemid 28145970)
26. Nitric oxide-induced apoptosis in pancreatic cells is mediated by the endoplasmic reticulum stress pathway. Oyadomari S, Takeda K, Masaki T, et al. National Acad Sciences 2001 98 10845 10850 10.1073/pnas.191207498 (Pubitemid 32878707)
27. Metabolic Syndrome insulin resistance syndrome. Li XJ, Relationship between insulin resistance with FFA and with blood lipid metabolism disorder, Li XJ, Volume 11 2nd 2006 159 176
28. Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. Davidson MH, Abate N, Ballantyne CM, et al. Clinical Lipidology 2008 2 436 446 10.1016/j.jacl.2008.10. 003 (Pubitemid 352795716)
29. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate inapob-lipoprotein- depleted plasma. Dobiásová M, Frohlichb J, Clin Biochem 2001 34 583 588 10.1016/S0009-9120(01)00263-6 11738396 (Pubitemid 34014853)
30. The Triglyceride-to-HDL Cholesterol Ratio. Giannini C, Santor N, Caprio S, et al. Diabetes Care 2011 34 1869 1874 10.2337/dc10-2234 21730284
31. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Heiss G, Tamir I, Davis CE, et al. Circulation 1980 61 302 315 10.1161/01.CIR.61.2.302 7351055 (Pubitemid 10214988)